Registry Study of Proton Radiotherapy in Lymphoma
ConditionMediastinal Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Heidelberg
About this trial
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient consent
Patient age ≥18 years.
Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
Ability of the patient to give consent
Disqualifiers
Non-consent of the patient to the disclosure of his data
Cancellation of the patient's participation in the study
Trial population
Patients with mediastinal lymphoma are recorded who require consolidating mediastinal radiotherapy as part of their primary therapy. Since there is no intervention in the registry study, patients who are being treated in a therapy study (e.g. in the context of the ongoing Hodgkin studies) can also be included.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Assesment of Effectiveness and side effects
Other interventionCase Report forms, Quality of life questionaire
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Acquisition and documentation of a mediastinal PT and the corresponding follow-up data
Effectiveness and side effects of proton radiotherapy
Time frame
From date of written informed consent until the date of death from any cause, assessed up to 100 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov